These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 17341176)

  • 1. Methods for treating cognitive deficits in schizophrenia.
    Bowie CR; Jaga K
    Expert Rev Neurother; 2007 Mar; 7(3):281-7. PubMed ID: 17341176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cognitive functioning in schizophrenia: a consensus statement on its role in the definition and evaluation of effective treatments for the illness.
    Harvey PD; Green MF; Keefe RS; Velligan DI
    J Clin Psychiatry; 2004 Mar; 65(3):361-72. PubMed ID: 15096076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence-based psychotherapy for schizophrenia.
    Dickerson FB; Lehman AF
    J Nerv Ment Dis; 2006 Jan; 194(1):3-9. PubMed ID: 16462548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cognitive deficits in schizophrenia and other psychotic disorders].
    Fagerlund B; Glenthøj BY
    Ugeskr Laeger; 2008 Nov; 170(46):3770-2. PubMed ID: 19014728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cognitive-behavioral therapy for medication-resistant schizophrenia: a review.
    Rathod S; Kingdon D; Weiden P; Turkington D
    J Psychiatr Pract; 2008 Jan; 14(1):22-33. PubMed ID: 18212600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predicting drug efficacy for cognitive deficits in schizophrenia.
    Hagan JJ; Jones DN
    Schizophr Bull; 2005 Oct; 31(4):830-53. PubMed ID: 16177277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of cognitive deficits in schizophrenia.
    Bowie CR; Harvey PD
    Curr Opin Investig Drugs; 2006 Jul; 7(7):608-13. PubMed ID: 16869112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Developing treatment guidelines for Alzheimer's disease and other dementias.
    Rabins PV
    J Clin Psychiatry; 1996; 57 Suppl 14():37-8. PubMed ID: 9024335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cognitive and psychomotor effects of risperidone in schizophrenia and schizoaffective disorder.
    Houthoofd SA; Morrens M; Sabbe BG
    Clin Ther; 2008 Sep; 30(9):1565-89. PubMed ID: 18840365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cognitive behavioral therapy for schizophrenia.
    Rathod S; Phiri P; Kingdon D
    Psychiatr Clin North Am; 2010 Sep; 33(3):527-36. PubMed ID: 20599131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rivastigmine treatment as an add-on to antipsychotics in patients with schizophrenia and cognitive deficits.
    Chouinard S; Stip E; Poulin J; Melun JP; Godbout R; Guillem F; Cohen H
    Curr Med Res Opin; 2007 Mar; 23(3):575-83. PubMed ID: 17355738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early intervention in patients at ultra high risk of psychosis: benefits and risks.
    de Koning MB; Bloemen OJ; van Amelsvoort TA; Becker HE; Nieman DH; van der Gaag M; Linszen DH
    Acta Psychiatr Scand; 2009 Jun; 119(6):426-42. PubMed ID: 19392813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advances in the treatment of schizophrenia.
    Kuperberg GR; Murray R
    Br J Clin Pract; 1996 Sep; 50(6):315-23. PubMed ID: 8983320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thinking and acting beyond the positive: the role of the cognitive and negative symptoms in schizophrenia.
    Carbon M; Correll CU
    CNS Spectr; 2014 Dec; 19 Suppl 1():38-52; quiz 35-7, 53. PubMed ID: 25403863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrating non-drug treatments in early schizophrenia.
    Lewis SW; Tarrier N; Drake RJ
    Br J Psychiatry Suppl; 2005 Aug; 48():s65-71. PubMed ID: 16055811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cognitive remediation and vocational rehabilitation for schizophrenia.
    Wexler BE; Bell MD
    Schizophr Bull; 2005 Oct; 31(4):931-41. PubMed ID: 16079390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rehabilitation and recovery in schizophrenia.
    Velligan DI; Gonzalez JM
    Psychiatr Clin North Am; 2007 Sep; 30(3):535-48. PubMed ID: 17720035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment pathway and patterns of clozapine prescribing for schizophrenia in New Zealand.
    Wheeler AJ
    Ann Pharmacother; 2008 Jun; 42(6):852-60. PubMed ID: 18477732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cognitive remediation in the treatment of stimulant abuse disorders: a research agenda.
    Vocci FJ
    Exp Clin Psychopharmacol; 2008 Dec; 16(6):484-97. PubMed ID: 19086769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Developing treatments for impaired cognition in schizophrenia.
    Minzenberg MJ; Carter CS
    Trends Cogn Sci; 2012 Jan; 16(1):35-42. PubMed ID: 22178120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.